Humoral and cellular immune response after severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination in heart transplant recipients: An observational study in France
Open Access
- 26 October 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 1027708
Abstract
Introduction: Heart transplant (HT) recipients have a high risk of developing severe COVID-19. Immunoglobulin G antibodies are considered to provide protective immunity and T-cell activity is thought to confer protection from severe disease. However, data on T-cell response to mRNA vaccination in a context of HT remains limited.Methods: In 96 HT patients, a IFN-γ release assay and an anti-Spike antibody test were used to evaluate the ability of SARS-CoV-2 mRNA vaccines to generate cellular and humoral immune response. Blood samples were collected few weeks to 7 months after vaccination. Multiple fractional polynomial and LASSO regression models were used to define predictors of T-cell response.Results: Three to five months after vaccination, three doses of vaccine induced a positive SARS-CoV-2 T-cell response in 47% of recipients and a positive humoral response in 83% of recipients, 11.1% of patients remained negative for both T and B cell responses. Three doses were necessary to reach high IgG response levels (>590 BAU/mL), which were obtained in a third of patients. Immunity was greatly amplified in the group who had three vaccine doses plus COVID-19 infection.Conclusion: Our study revealed that T and B immunity decreases over time, leading us to suggest the interest of a booster vaccination at 5 months after the third dose. Moreover, a close follow-up of immune response following vaccination is needed to ensure ongoing immune protection. We also found that significant predictors of higher cellular response were infection and active smoking, regardless of immunosuppressive treatment with mycophenolate mofetil (MMF).Keywords
This publication has 63 references indexed in Scilit:
- Impact of COVID-19 in solid organ transplant recipientsAmerican Journal of Transplantation, 2022
- Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cellsNature Medicine, 2020
- COVID-19 and Solid Organ Transplantation: A Review ArticleTransplantation, 2020
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease SeverityCell, 2020
- Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019JAMA Cardiology, 2020
- COVID-19 Mortality in Transplant Recipients2020
- Multivariable fractional polynomial method for regression modelAnnals of Translational Medicine, 2016
- Lasso Regression: Estimation and Shrinkage via the Limit of Gibbs SamplingJournal of the Royal Statistical Society Series B: Statistical Methodology, 2015
- Building Multivariable Prognostic and Diagnostic Models: Transformation of the Predictors by Using Fractional PolynomialsJournal of the Royal Statistical Society Series A: Statistics in Society, 1999
- Regression Using Fractional Polynomials of Continuous Covariates: Parsimonious Parametric ModellingJournal of the Royal Statistical Society Series C: Applied Statistics, 1994